Ozaki Y - Search Results

1

Humanized anti-HM1.24 antibody mediates myeloma cell cytotoxicity that is enhanced by cytokine stimulation of effector cells.

Ozaki S, Kosaka M, Wakahara Y, Ozaki Y, Tsuchiya M, Koishihara Y, Goto T, Matsumoto T. Ozaki S, et al. Among authors: ozaki y. Blood. 1999 Jun 1;93(11):3922-30. Blood. 1999. PMID: 10339501 Free article.

2

Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells.

Ohtomo T, Sugamata Y, Ozaki Y, Ono K, Yoshimura Y, Kawai S, Koishihara Y, Ozaki S, Kosaka M, Hirano T, Tsuchiya M. Ohtomo T, et al. Among authors: ozaki y, ozaki s. Biochem Biophys Res Commun. 1999 May 19;258(3):583-91. doi: 10.1006/bbrc.1999.0683. Biochem Biophys Res Commun. 1999. PMID: 10329429

3

A novel phthalimide derivative, TC11, has preclinical effects on high-risk myeloma cells and osteoclasts.

Matsushita M, Ozaki Y, Hasegawa Y, Terada F, Tabata N, Shiheido H, Yanagawa H, Oikawa T, Matsuo K, Du W, Yamada T, Hozumi M, Ichikawa D, Hattori Y. Matsushita M, et al. Among authors: ozaki y. PLoS One. 2015 Jan 24;10(1):e0116135. doi: 10.1371/journal.pone.0116135. eCollection 2015. PLoS One. 2015. PMID: 25617756 Free PMC article.

4

Influence of Worsening Renal Function and Baseline Chronic Kidney Disease on Clinical Outcomes in Patients With Chronic Coronary Syndromes: Insights From the REAL-CAD Study.

Yoshiki Y, Ozaki Y, Abe M, Ismail TF, Takahashi H, Akao M, Kawai H, Muramatsu T, Harada M, Ohta M, Hashimoto Y, Shiki Y, Koshikawa M, Miyajima K, Takatsu H, Niwa Y, Kawashima N, Ozaki R, Tsuboi N, Iimuro S, Iwata H, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Fukumoto Y, Hokimoto S, Miyauchi K, Ogawa H, Daida H, Shimokawa H, Izawa H, Kimura T, Nagai R; REAL‐CAD investigators. Yoshiki Y, et al. Among authors: ozaki y. J Am Heart Assoc. 2025 Jan 17:e034627. doi: 10.1161/JAHA.124.034627. Online ahead of print. J Am Heart Assoc. 2025. PMID: 39818975

5

Real-world antithrombotic strategies in patients with atrial fibrillation and recently developed acute coronary syndrome.

Iwata H, Miyauchi K, Nojiri S, Nishizaki Y, Chikata Y, Daida H; STAR-ACS investigators. Iwata H, et al. Int J Cardiol Cardiovasc Risk Prev. 2024 Oct 8;24:200339. doi: 10.1016/j.ijcrp.2024.200339. eCollection 2025 Mar. Int J Cardiol Cardiovasc Risk Prev. 2024. PMID: 39760131 Free PMC article.

6

Tumor β-Catenin Expression Associated With Poor Prognosis to Anti-PD-1 Antibody Monotherapy in Non-small Cell Lung Cancer.

Muto S, Ozaki Y, Yamaguchi H, Watanabe M, Okabe N, Matsumura Y, Hamada K, Suzuki H. Muto S, et al. Among authors: ozaki y. Cancer Diagn Progn. 2025 Jan 3;5(1):32-41. doi: 10.21873/cdp.10409. eCollection 2025 Jan-Feb. Cancer Diagn Progn. 2025. PMID: 39758230 Free PMC article.

7

Clinical implications of cerebral microbleeds in patients who undergo transcatheter aortic valve replacement.

Uemura Y, Tanaka A, Ozaki Y, Yamaguchi S, Okajima T, Mitsuda T, Ishikawa S, Takemoto K, Murohara T, Watarai M. Uemura Y, et al. Among authors: ozaki y. Cardiovasc Revasc Med. 2024 Dec 28:S1553-8389(24)00759-0. doi: 10.1016/j.carrev.2024.12.013. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 39755529

8

Impact of sodium-glucose cotransporter 2 inhibitors on catheter ablation for atrial fibrillation in heart failure patients without type-2 diabetes.

Harada M, Motoike Y, Nomura Y, Nishimura A, Koshikawa M, Watanabe E, Ozaki Y, Izawa H. Harada M, et al. Among authors: ozaki y. Int J Cardiol. 2025 Jan 2;422:132954. doi: 10.1016/j.ijcard.2024.132954. Online ahead of print. Int J Cardiol. 2025. PMID: 39755334 Free article.

9

A competitive dual-mode for tetracycline antibiotics sensing based on colorimetry and surface-enhanced Raman scattering.

Qi J, Wan Y, Li J, Jiang G, Wang J, Ozaki Y, Pi F. Qi J, et al. Among authors: ozaki y. Biosens Bioelectron. 2024 Dec 30;272:117114. doi: 10.1016/j.bios.2024.117114. Online ahead of print. Biosens Bioelectron. 2024. PMID: 39752887

10

Supraclavicular Irradiation Induces Lymphedema in Breast Cancer Patients Treated with Axillary Lymph Node Dissection and Taxane-Containing Chemotherapy.

Horisawa N, Yoshimura A, Oze I, Sawaki M, Hattori M, Kotani H, Kataoka A, Ozaki Y, Nozawa K, Endo Y, Takatsuka D, Isogai A, Iwata H. Horisawa N, et al. Among authors: ozaki y. Breast J. 2024 Jul 31;2024:3250143. doi: 10.1155/2024/3250143. eCollection 2024. Breast J. 2024. PMID: 39742367 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,156 results

Search Page

Filters